nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—CYP2C9—Glyburide—gestational diabetes	0.0908	0.392	CbGbCtD
Carvedilol—ABCB1—Glyburide—gestational diabetes	0.0881	0.38	CbGbCtD
Carvedilol—VCAM1—tunica intima—gestational diabetes	0.0636	0.159	CbGeAlD
Carvedilol—CYP3A4—Glyburide—gestational diabetes	0.0528	0.228	CbGbCtD
Carvedilol—SELE—umbilical vein—gestational diabetes	0.0422	0.105	CbGeAlD
Carvedilol—VCAM1—umbilical vein—gestational diabetes	0.0388	0.097	CbGeAlD
Carvedilol—Cerebrovascular disorder—Glyburide—gestational diabetes	0.0157	0.0846	CcSEcCtD
Carvedilol—Kidney function abnormal—Glyburide—gestational diabetes	0.0146	0.0782	CcSEcCtD
Carvedilol—VCAM1—islet of Langerhans—gestational diabetes	0.0105	0.0261	CbGeAlD
Carvedilol—HIF1A—islet of Langerhans—gestational diabetes	0.0101	0.0252	CbGeAlD
Carvedilol—GJA1—islet of Langerhans—gestational diabetes	0.00976	0.0244	CbGeAlD
Carvedilol—HIF1A—embryo—gestational diabetes	0.00973	0.0243	CbGeAlD
Carvedilol—GJA1—embryo—gestational diabetes	0.00944	0.0236	CbGeAlD
Carvedilol—Coagulopathy—Glyburide—gestational diabetes	0.00903	0.0486	CcSEcCtD
Carvedilol—NPPB—head—gestational diabetes	0.00824	0.0206	CbGeAlD
Carvedilol—Hyperbilirubinaemia—Glyburide—gestational diabetes	0.00773	0.0416	CcSEcCtD
Carvedilol—VEGFA—islet of Langerhans—gestational diabetes	0.00771	0.0193	CbGeAlD
Carvedilol—SELE—uterus—gestational diabetes	0.00741	0.0185	CbGeAlD
Carvedilol—SELE—adipose tissue—gestational diabetes	0.00725	0.0181	CbGeAlD
Carvedilol—VCAM1—uterus—gestational diabetes	0.00682	0.0171	CbGeAlD
Carvedilol—VCAM1—adipose tissue—gestational diabetes	0.00667	0.0167	CbGeAlD
Carvedilol—Aplastic anaemia—Glyburide—gestational diabetes	0.0066	0.0355	CcSEcCtD
Carvedilol—HIF1A—uterus—gestational diabetes	0.00656	0.0164	CbGeAlD
Carvedilol—HIF1A—adipose tissue—gestational diabetes	0.00642	0.016	CbGeAlD
Carvedilol—GJA1—uterus—gestational diabetes	0.00636	0.0159	CbGeAlD
Carvedilol—GJA1—adipose tissue—gestational diabetes	0.00622	0.0156	CbGeAlD
Carvedilol—SELE—vagina—gestational diabetes	0.00603	0.0151	CbGeAlD
Carvedilol—Vascular purpura—Glyburide—gestational diabetes	0.00571	0.0307	CcSEcCtD
Carvedilol—ADRB3—adipose tissue—gestational diabetes	0.0057	0.0143	CbGeAlD
Carvedilol—SELE—head—gestational diabetes	0.00557	0.0139	CbGeAlD
Carvedilol—VCAM1—vagina—gestational diabetes	0.00554	0.0139	CbGeAlD
Carvedilol—NDUFC2—uterus—gestational diabetes	0.00554	0.0139	CbGeAlD
Carvedilol—Renal failure acute—Glyburide—gestational diabetes	0.00553	0.0297	CcSEcCtD
Carvedilol—NDUFC2—adipose tissue—gestational diabetes	0.00542	0.0135	CbGeAlD
Carvedilol—Renal impairment—Glyburide—gestational diabetes	0.00536	0.0288	CcSEcCtD
Carvedilol—HIF1A—vagina—gestational diabetes	0.00533	0.0133	CbGeAlD
Carvedilol—Purpura—Glyburide—gestational diabetes	0.0053	0.0285	CcSEcCtD
Carvedilol—Arthritis—Glyburide—gestational diabetes	0.00525	0.0282	CcSEcCtD
Carvedilol—Hypoglycaemia—Glyburide—gestational diabetes	0.00523	0.0281	CcSEcCtD
Carvedilol—GJA1—vagina—gestational diabetes	0.00517	0.0129	CbGeAlD
Carvedilol—Hyponatraemia—Glyburide—gestational diabetes	0.00513	0.0276	CcSEcCtD
Carvedilol—VCAM1—head—gestational diabetes	0.00512	0.0128	CbGeAlD
Carvedilol—VEGFA—uterus—gestational diabetes	0.00502	0.0126	CbGeAlD
Carvedilol—HIF1A—head—gestational diabetes	0.00493	0.0123	CbGeAlD
Carvedilol—VEGFA—adipose tissue—gestational diabetes	0.00491	0.0123	CbGeAlD
Carvedilol—GJA1—head—gestational diabetes	0.00478	0.012	CbGeAlD
Carvedilol—NDUFC2—vagina—gestational diabetes	0.0045	0.0113	CbGeAlD
Carvedilol—Sweating increased—Glyburide—gestational diabetes	0.0043	0.0231	CcSEcCtD
Carvedilol—Pancytopenia—Glyburide—gestational diabetes	0.00419	0.0225	CcSEcCtD
Carvedilol—NDUFC2—head—gestational diabetes	0.00416	0.0104	CbGeAlD
Carvedilol—VEGFA—vagina—gestational diabetes	0.00409	0.0102	CbGeAlD
Carvedilol—Photosensitivity reaction—Glyburide—gestational diabetes	0.00403	0.0217	CcSEcCtD
Carvedilol—XDH—vagina—gestational diabetes	0.00364	0.00909	CbGeAlD
Carvedilol—Visual impairment—Glyburide—gestational diabetes	0.0034	0.0183	CcSEcCtD
Carvedilol—Alopecia—Glyburide—gestational diabetes	0.00312	0.0168	CcSEcCtD
Carvedilol—Malnutrition—Glyburide—gestational diabetes	0.00307	0.0165	CcSEcCtD
Carvedilol—Vision blurred—Glyburide—gestational diabetes	0.0029	0.0156	CcSEcCtD
Carvedilol—Anaemia—Glyburide—gestational diabetes	0.00284	0.0153	CcSEcCtD
Carvedilol—Angioedema—Glyburide—gestational diabetes	0.00281	0.0151	CcSEcCtD
Carvedilol—KCNH2—islet of Langerhans—gestational diabetes	0.00279	0.00698	CbGeAlD
Carvedilol—Leukopenia—Glyburide—gestational diabetes	0.00275	0.0148	CcSEcCtD
Carvedilol—Convulsion—Glyburide—gestational diabetes	0.00266	0.0143	CcSEcCtD
Carvedilol—Arthralgia—Glyburide—gestational diabetes	0.00262	0.0141	CcSEcCtD
Carvedilol—Myalgia—Glyburide—gestational diabetes	0.00262	0.0141	CcSEcCtD
Carvedilol—Confusional state—Glyburide—gestational diabetes	0.00253	0.0136	CcSEcCtD
Carvedilol—ADRA1B—head—gestational diabetes	0.00252	0.0063	CbGeAlD
Carvedilol—Oedema—Glyburide—gestational diabetes	0.00251	0.0135	CcSEcCtD
Carvedilol—Shock—Glyburide—gestational diabetes	0.00247	0.0133	CcSEcCtD
Carvedilol—ADRA1D—head—gestational diabetes	0.00247	0.00617	CbGeAlD
Carvedilol—Thrombocytopenia—Glyburide—gestational diabetes	0.00246	0.0132	CcSEcCtD
Carvedilol—Hyperhidrosis—Glyburide—gestational diabetes	0.00243	0.013	CcSEcCtD
Carvedilol—Anorexia—Glyburide—gestational diabetes	0.00239	0.0129	CcSEcCtD
Carvedilol—Hypotension—Glyburide—gestational diabetes	0.00234	0.0126	CcSEcCtD
Carvedilol—ADRB1—adipose tissue—gestational diabetes	0.00233	0.00583	CbGeAlD
Carvedilol—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.00229	0.0123	CcSEcCtD
Carvedilol—Paraesthesia—Glyburide—gestational diabetes	0.00225	0.0121	CcSEcCtD
Carvedilol—Dyspnoea—Glyburide—gestational diabetes	0.00224	0.012	CcSEcCtD
Carvedilol—Dyspepsia—Glyburide—gestational diabetes	0.00221	0.0119	CcSEcCtD
Carvedilol—ADRA2A—islet of Langerhans—gestational diabetes	0.0022	0.0055	CbGeAlD
Carvedilol—Decreased appetite—Glyburide—gestational diabetes	0.00218	0.0117	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Glyburide—gestational diabetes	0.00217	0.0116	CcSEcCtD
Carvedilol—Feeling abnormal—Glyburide—gestational diabetes	0.00207	0.0111	CcSEcCtD
Carvedilol—Gastrointestinal pain—Glyburide—gestational diabetes	0.00205	0.011	CcSEcCtD
Carvedilol—Urticaria—Glyburide—gestational diabetes	0.00199	0.0107	CcSEcCtD
Carvedilol—Abdominal pain—Glyburide—gestational diabetes	0.00198	0.0107	CcSEcCtD
Carvedilol—Hypersensitivity—Glyburide—gestational diabetes	0.00185	0.00994	CcSEcCtD
Carvedilol—ADRA1A—adipose tissue—gestational diabetes	0.00184	0.00461	CbGeAlD
Carvedilol—KCNH2—uterus—gestational diabetes	0.00182	0.00455	CbGeAlD
Carvedilol—Asthenia—Glyburide—gestational diabetes	0.0018	0.00968	CcSEcCtD
Carvedilol—ADRA2C—uterus—gestational diabetes	0.0018	0.00449	CbGeAlD
Carvedilol—ADRB1—head—gestational diabetes	0.00179	0.00448	CbGeAlD
Carvedilol—Pruritus—Glyburide—gestational diabetes	0.00178	0.00954	CcSEcCtD
Carvedilol—ADRA2C—adipose tissue—gestational diabetes	0.00176	0.00439	CbGeAlD
Carvedilol—Diarrhoea—Glyburide—gestational diabetes	0.00172	0.00923	CcSEcCtD
Carvedilol—Vomiting—Glyburide—gestational diabetes	0.0016	0.00858	CcSEcCtD
Carvedilol—Rash—Glyburide—gestational diabetes	0.00158	0.00851	CcSEcCtD
Carvedilol—Dermatitis—Glyburide—gestational diabetes	0.00158	0.0085	CcSEcCtD
Carvedilol—Headache—Glyburide—gestational diabetes	0.00157	0.00845	CcSEcCtD
Carvedilol—CYP1A1—uterus—gestational diabetes	0.00154	0.00385	CbGeAlD
Carvedilol—CYP1A1—adipose tissue—gestational diabetes	0.0015	0.00376	CbGeAlD
Carvedilol—Nausea—Glyburide—gestational diabetes	0.00149	0.00801	CcSEcCtD
Carvedilol—KCNH2—vagina—gestational diabetes	0.00148	0.0037	CbGeAlD
Carvedilol—ADRA2C—vagina—gestational diabetes	0.00146	0.00365	CbGeAlD
Carvedilol—ADRA2A—uterus—gestational diabetes	0.00143	0.00359	CbGeAlD
Carvedilol—ADRA1A—head—gestational diabetes	0.00142	0.00354	CbGeAlD
Carvedilol—ADRA2A—adipose tissue—gestational diabetes	0.0014	0.00351	CbGeAlD
Carvedilol—KCNH2—head—gestational diabetes	0.00137	0.00342	CbGeAlD
Carvedilol—PTGS1—uterus—gestational diabetes	0.00135	0.00338	CbGeAlD
Carvedilol—ADRA2C—head—gestational diabetes	0.00135	0.00337	CbGeAlD
Carvedilol—PTGS1—adipose tissue—gestational diabetes	0.00132	0.0033	CbGeAlD
Carvedilol—CYP1A1—vagina—gestational diabetes	0.00125	0.00313	CbGeAlD
Carvedilol—ABCB1—islet of Langerhans—gestational diabetes	0.00123	0.00306	CbGeAlD
Carvedilol—ABCB1—embryo—gestational diabetes	0.00118	0.00296	CbGeAlD
Carvedilol—ADRA2A—vagina—gestational diabetes	0.00117	0.00291	CbGeAlD
Carvedilol—CYP1A1—head—gestational diabetes	0.00116	0.00289	CbGeAlD
Carvedilol—PTGS1—vagina—gestational diabetes	0.0011	0.00275	CbGeAlD
Carvedilol—ADRA2A—head—gestational diabetes	0.00108	0.00269	CbGeAlD
Carvedilol—CYP2E1—head—gestational diabetes	0.00105	0.00263	CbGeAlD
Carvedilol—ADRB3—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.00102	0.0056	CbGpPWpGaD
Carvedilol—PTGS1—head—gestational diabetes	0.00101	0.00254	CbGeAlD
Carvedilol—ADRA1A—AMPK Signaling—ADIPOQ—gestational diabetes	0.00101	0.00552	CbGpPWpGaD
Carvedilol—CYP1A1—Biological oxidations—GGCT—gestational diabetes	0.000996	0.00546	CbGpPWpGaD
Carvedilol—CYP1A1—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000996	0.00546	CbGpPWpGaD
Carvedilol—VEGFA—Integrated Breast Cancer Pathway—CYP19A1—gestational diabetes	0.000994	0.00545	CbGpPWpGaD
Carvedilol—VEGFA—Integrated Breast Cancer Pathway—AR—gestational diabetes	0.000967	0.0053	CbGpPWpGaD
Carvedilol—VEGFA—SIDS Susceptibility Pathways—AR—gestational diabetes	0.000942	0.00516	CbGpPWpGaD
Carvedilol—GJA1—Spinal Cord Injury—TNF—gestational diabetes	0.000941	0.00516	CbGpPWpGaD
Carvedilol—PTGS1—Overview of nanoparticle effects—TNF—gestational diabetes	0.000928	0.00508	CbGpPWpGaD
Carvedilol—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000926	0.00508	CbGpPWpGaD
Carvedilol—VCAM1—Extracellular matrix organization—FGF2—gestational diabetes	0.000883	0.00484	CbGpPWpGaD
Carvedilol—ADRB3—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000875	0.0048	CbGpPWpGaD
Carvedilol—KCNH2—SIDS Susceptibility Pathways—AR—gestational diabetes	0.000854	0.00468	CbGpPWpGaD
Carvedilol—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000854	0.00468	CbGpPWpGaD
Carvedilol—CYP2E1—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000843	0.00462	CbGpPWpGaD
Carvedilol—HIF1A—Adipogenesis—TNF—gestational diabetes	0.00084	0.0046	CbGpPWpGaD
Carvedilol—CYP2D6—head—gestational diabetes	0.000834	0.00209	CbGeAlD
Carvedilol—VEGFA—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000832	0.00456	CbGpPWpGaD
Carvedilol—ABCB1—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.000815	0.00446	CbGpPWpGaD
Carvedilol—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000805	0.00441	CbGpPWpGaD
Carvedilol—VEGFA—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000801	0.00439	CbGpPWpGaD
Carvedilol—ABCB1—uterus—gestational diabetes	0.000799	0.002	CbGeAlD
Carvedilol—CYP1A1—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000794	0.00435	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—MBL2—gestational diabetes	0.000788	0.00432	CbGpPWpGaD
Carvedilol—ABCB1—adipose tissue—gestational diabetes	0.000781	0.00195	CbGeAlD
Carvedilol—GJA1—SIDS Susceptibility Pathways—TNF—gestational diabetes	0.000753	0.00413	CbGpPWpGaD
Carvedilol—CYP2D6—Biological oxidations—GGCT—gestational diabetes	0.00075	0.00411	CbGpPWpGaD
Carvedilol—CYP2C9—Biological oxidations—GGCT—gestational diabetes	0.000743	0.00407	CbGpPWpGaD
Carvedilol—HIF1A—SIDS Susceptibility Pathways—TNF—gestational diabetes	0.000726	0.00398	CbGpPWpGaD
Carvedilol—ADRA1B—AMPK Signaling—LEP—gestational diabetes	0.000705	0.00386	CbGpPWpGaD
Carvedilol—CYP2E1—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000692	0.00379	CbGpPWpGaD
Carvedilol—ADRB3—GPCR ligand binding—MTNR1B—gestational diabetes	0.000666	0.00365	CbGpPWpGaD
Carvedilol—ADRA1D—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000665	0.00365	CbGpPWpGaD
Carvedilol—CYP1A1—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000653	0.00358	CbGpPWpGaD
Carvedilol—HIF1A—Disease—RBP4—gestational diabetes	0.00065	0.00356	CbGpPWpGaD
Carvedilol—ABCB1—vagina—gestational diabetes	0.000649	0.00162	CbGeAlD
Carvedilol—ADRA2B—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.000647	0.00355	CbGpPWpGaD
Carvedilol—CYP1A2—Biological oxidations—GGCT—gestational diabetes	0.000635	0.00348	CbGpPWpGaD
Carvedilol—CYP1A2—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000635	0.00348	CbGpPWpGaD
Carvedilol—NDUFC2—Metabolism—NAMPT—gestational diabetes	0.000633	0.00347	CbGpPWpGaD
Carvedilol—NDUFC2—Metabolism—GCK—gestational diabetes	0.000629	0.00345	CbGpPWpGaD
Carvedilol—ADRA1A—AMPK Signaling—LEP—gestational diabetes	0.000626	0.00343	CbGpPWpGaD
Carvedilol—ADRB1—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000606	0.00332	CbGpPWpGaD
Carvedilol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000606	0.00332	CbGpPWpGaD
Carvedilol—ADRA2C—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.000605	0.00331	CbGpPWpGaD
Carvedilol—ADRA2B—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000601	0.00329	CbGpPWpGaD
Carvedilol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000601	0.00329	CbGpPWpGaD
Carvedilol—ABCB1—head—gestational diabetes	0.0006	0.0015	CbGeAlD
Carvedilol—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000598	0.00328	CbGpPWpGaD
Carvedilol—ADRB2—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000593	0.00325	CbGpPWpGaD
Carvedilol—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000593	0.00325	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—LEPR—gestational diabetes	0.000591	0.00324	CbGpPWpGaD
Carvedilol—HIF1A—Disease—NAMPT—gestational diabetes	0.000583	0.0032	CbGpPWpGaD
Carvedilol—XDH—Selenium Micronutrient Network—TNF—gestational diabetes	0.000581	0.00319	CbGpPWpGaD
Carvedilol—HIF1A—Disease—GCK—gestational diabetes	0.000579	0.00318	CbGpPWpGaD
Carvedilol—ADRA1D—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.00057	0.00312	CbGpPWpGaD
Carvedilol—ADRA2C—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000561	0.00308	CbGpPWpGaD
Carvedilol—ADRA1B—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000552	0.00303	CbGpPWpGaD
Carvedilol—VEGFA—Allograft Rejection—TNF—gestational diabetes	0.00054	0.00296	CbGpPWpGaD
Carvedilol—VEGFA—Developmental Biology—GCK—gestational diabetes	0.000527	0.00289	CbGpPWpGaD
Carvedilol—ADRB1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000519	0.00285	CbGpPWpGaD
Carvedilol—XDH—Metabolism—GGCT—gestational diabetes	0.000516	0.00283	CbGpPWpGaD
Carvedilol—ADRA2B—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000515	0.00282	CbGpPWpGaD
Carvedilol—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000513	0.00281	CbGpPWpGaD
Carvedilol—ADRB2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000508	0.00278	CbGpPWpGaD
Carvedilol—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000506	0.00278	CbGpPWpGaD
Carvedilol—PTGS1—Biological oxidations—CYP19A1—gestational diabetes	0.000492	0.0027	CbGpPWpGaD
Carvedilol—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000491	0.00269	CbGpPWpGaD
Carvedilol—ADRA2A—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.000491	0.00269	CbGpPWpGaD
Carvedilol—ADRA1A—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000491	0.00269	CbGpPWpGaD
Carvedilol—CYP3A4—Biological oxidations—GGCT—gestational diabetes	0.00049	0.00269	CbGpPWpGaD
Carvedilol—CYP3A4—Tryptophan metabolism—CYP19A1—gestational diabetes	0.00049	0.00268	CbGpPWpGaD
Carvedilol—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000487	0.00267	CbGpPWpGaD
Carvedilol—ADRA2C—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000481	0.00263	CbGpPWpGaD
Carvedilol—ADRA1B—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000473	0.00259	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—MTNR1B—gestational diabetes	0.000467	0.00256	CbGpPWpGaD
Carvedilol—NDUFC2—Metabolism—CYP19A1—gestational diabetes	0.00046	0.00252	CbGpPWpGaD
Carvedilol—ADRA2A—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000456	0.0025	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—RBP4—gestational diabetes	0.000455	0.00249	CbGpPWpGaD
Carvedilol—VCAM1—Adaptive Immune System—FGF2—gestational diabetes	0.000454	0.00249	CbGpPWpGaD
Carvedilol—XDH—Metabolism—GLS2—gestational diabetes	0.000451	0.00247	CbGpPWpGaD
Carvedilol—VEGFA—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000438	0.0024	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR ligand binding—MTNR1B—gestational diabetes	0.000434	0.00238	CbGpPWpGaD
Carvedilol—VEGFA—Developmental Biology—ADIPOQ—gestational diabetes	0.000434	0.00238	CbGpPWpGaD
Carvedilol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.00042	0.0023	CbGpPWpGaD
Carvedilol—ABCB1—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.000417	0.00228	CbGpPWpGaD
Carvedilol—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000416	0.00228	CbGpPWpGaD
Carvedilol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000396	0.00217	CbGpPWpGaD
Carvedilol—ADRB1—GPCR ligand binding—MTNR1B—gestational diabetes	0.000396	0.00217	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR ligand binding—MTNR1B—gestational diabetes	0.000392	0.00215	CbGpPWpGaD
Carvedilol—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000391	0.00214	CbGpPWpGaD
Carvedilol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.00039	0.00214	CbGpPWpGaD
Carvedilol—ADRB2—GPCR ligand binding—MTNR1B—gestational diabetes	0.000387	0.00212	CbGpPWpGaD
Carvedilol—ADRB3—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000377	0.00206	CbGpPWpGaD
Carvedilol—CYP2E1—Biological oxidations—CYP19A1—gestational diabetes	0.000368	0.00201	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR ligand binding—MTNR1B—gestational diabetes	0.000366	0.00201	CbGpPWpGaD
Carvedilol—CYP2E1—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000363	0.00199	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR ligand binding—MTNR1B—gestational diabetes	0.00036	0.00197	CbGpPWpGaD
Carvedilol—CYP1A1—Biological oxidations—CYP19A1—gestational diabetes	0.000347	0.0019	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—MTNR1B—gestational diabetes	0.000342	0.00187	CbGpPWpGaD
Carvedilol—CYP1A1—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000342	0.00187	CbGpPWpGaD
Carvedilol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000322	0.00177	CbGpPWpGaD
Carvedilol—CYP1A1—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000322	0.00177	CbGpPWpGaD
Carvedilol—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000321	0.00176	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR ligand binding—MTNR1B—gestational diabetes	0.00032	0.00175	CbGpPWpGaD
Carvedilol—VEGFA—SIDS Susceptibility Pathways—TNF—gestational diabetes	0.000313	0.00172	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR ligand binding—MTNR1B—gestational diabetes	0.000297	0.00163	CbGpPWpGaD
Carvedilol—KCNH2—SIDS Susceptibility Pathways—TNF—gestational diabetes	0.000284	0.00156	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—FGF2—gestational diabetes	0.000275	0.00151	CbGpPWpGaD
Carvedilol—PTGS1—Selenium Micronutrient Network—TNF—gestational diabetes	0.000272	0.00149	CbGpPWpGaD
Carvedilol—VEGFA—Developmental Biology—LEP—gestational diabetes	0.000269	0.00148	CbGpPWpGaD
Carvedilol—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000266	0.00146	CbGpPWpGaD
Carvedilol—CYP2D6—Biological oxidations—CYP19A1—gestational diabetes	0.000261	0.00143	CbGpPWpGaD
Carvedilol—CYP2C9—Biological oxidations—CYP19A1—gestational diabetes	0.000259	0.00142	CbGpPWpGaD
Carvedilol—CYP2D6—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000257	0.00141	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—LEPR—gestational diabetes	0.000256	0.0014	CbGpPWpGaD
Carvedilol—CYP2C9—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000255	0.0014	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—LEPR—gestational diabetes	0.000255	0.0014	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000248	0.00136	CbGpPWpGaD
Carvedilol—XDH—Metabolism—NAMPT—gestational diabetes	0.000247	0.00136	CbGpPWpGaD
Carvedilol—XDH—Metabolism—GCK—gestational diabetes	0.000246	0.00135	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000245	0.00134	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—GGCT—gestational diabetes	0.000242	0.00133	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—GGCT—gestational diabetes	0.000242	0.00132	CbGpPWpGaD
Carvedilol—HIF1A—Disease—FGF2—gestational diabetes	0.000225	0.00123	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000224	0.00122	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—MTNR1B—gestational diabetes	0.000223	0.00122	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000221	0.00121	CbGpPWpGaD
Carvedilol—CYP1A2—Biological oxidations—CYP19A1—gestational diabetes	0.000221	0.00121	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000219	0.0012	CbGpPWpGaD
Carvedilol—CYP1A2—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000218	0.00119	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—GLS2—gestational diabetes	0.000212	0.00116	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—GLS2—gestational diabetes	0.000211	0.00116	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—LEP—gestational diabetes	0.000208	0.00114	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000207	0.00113	CbGpPWpGaD
Carvedilol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000205	0.00113	CbGpPWpGaD
Carvedilol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000205	0.00113	CbGpPWpGaD
Carvedilol—VEGFA—Developmental Biology—FGF2—gestational diabetes	0.000205	0.00112	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000204	0.00112	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—MTNR1B—gestational diabetes	0.000203	0.00111	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—MTNR1B—gestational diabetes	0.000202	0.00111	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—MTNR1B—gestational diabetes	0.000202	0.0011	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—MTNR1B—gestational diabetes	0.000201	0.0011	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—MTNR1B—gestational diabetes	0.000199	0.00109	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—RBP4—gestational diabetes	0.000197	0.00108	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—GGCT—gestational diabetes	0.000197	0.00108	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—RBP4—gestational diabetes	0.000196	0.00108	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000189	0.00104	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—MTNR1B—gestational diabetes	0.000188	0.00103	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—MTNR1B—gestational diabetes	0.000185	0.00101	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000181	0.000991	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—GGCT—gestational diabetes	0.000181	0.00099	CbGpPWpGaD
Carvedilol—XDH—Metabolism—CYP19A1—gestational diabetes	0.00018	0.000985	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—GLS2—gestational diabetes	0.000172	0.000942	CbGpPWpGaD
Carvedilol—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	0.000171	0.000935	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—GGCT—gestational diabetes	0.00017	0.000934	CbGpPWpGaD
Carvedilol—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000168	0.000922	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000168	0.000921	CbGpPWpGaD
Carvedilol—ABCB1—Allograft Rejection—TNF—gestational diabetes	0.000167	0.000915	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—LEPR—gestational diabetes	0.000166	0.000912	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—MTNR1B—gestational diabetes	0.000164	0.0009	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—GLS2—gestational diabetes	0.000158	0.000865	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—FGF2—gestational diabetes	0.000158	0.000864	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—MTNR1B—gestational diabetes	0.000153	0.000836	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—LEPR—gestational diabetes	0.000152	0.000831	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—LEPR—gestational diabetes	0.00015	0.000824	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—GLS2—gestational diabetes	0.000149	0.000816	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—LEPR—gestational diabetes	0.000148	0.000813	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—LEPR—gestational diabetes	0.00014	0.000769	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000138	0.000758	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—LEPR—gestational diabetes	0.000138	0.000757	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—GGCT—gestational diabetes	0.000136	0.000746	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000135	0.000741	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000133	0.000729	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—MTNR1B—gestational diabetes	0.000132	0.000721	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—RBP4—gestational diabetes	0.000128	0.000703	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GGCT—gestational diabetes	0.000128	0.000703	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GGCT—gestational diabetes	0.000127	0.000697	CbGpPWpGaD
Carvedilol—VEGFA—Developmental Biology—TNF—gestational diabetes	0.000125	0.000683	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—LEPR—gestational diabetes	0.000123	0.000673	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MTNR1B—gestational diabetes	0.00012	0.000657	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—GLS2—gestational diabetes	0.000119	0.000652	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MTNR1B—gestational diabetes	0.000119	0.000651	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MTNR1B—gestational diabetes	0.000117	0.000643	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—RBP4—gestational diabetes	0.000117	0.00064	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—NAMPT—gestational diabetes	0.000116	0.000636	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—NAMPT—gestational diabetes	0.000116	0.000635	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—RBP4—gestational diabetes	0.000116	0.000635	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—GCK—gestational diabetes	0.000115	0.000632	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—GCK—gestational diabetes	0.000115	0.000631	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—RBP4—gestational diabetes	0.000114	0.000626	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—LEPR—gestational diabetes	0.000114	0.000625	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GLS2—gestational diabetes	0.000112	0.000614	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GLS2—gestational diabetes	0.000111	0.000609	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MTNR1B—gestational diabetes	0.000111	0.000608	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MTNR1B—gestational diabetes	0.000109	0.000599	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GGCT—gestational diabetes	0.000109	0.000595	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—RBP4—gestational diabetes	0.000108	0.000593	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—RBP4—gestational diabetes	0.000106	0.000583	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	9.93e-05	0.000544	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MTNR1B—gestational diabetes	9.7e-05	0.000532	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GLS2—gestational diabetes	9.49e-05	0.00052	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—RBP4—gestational diabetes	9.45e-05	0.000518	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—NAMPT—gestational diabetes	9.42e-05	0.000516	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—GCK—gestational diabetes	9.36e-05	0.000513	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MTNR1B—gestational diabetes	9.01e-05	0.000494	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—LEP—gestational diabetes	8.98e-05	0.000492	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—LEP—gestational diabetes	8.96e-05	0.000491	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—RBP4—gestational diabetes	8.78e-05	0.000481	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—NAMPT—gestational diabetes	8.65e-05	0.000474	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—GCK—gestational diabetes	8.6e-05	0.000471	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	8.49e-05	0.000465	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—CYP19A1—gestational diabetes	8.43e-05	0.000462	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—CYP19A1—gestational diabetes	8.41e-05	0.000461	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GGCT—gestational diabetes	8.38e-05	0.000459	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	8.24e-05	0.000451	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—NAMPT—gestational diabetes	8.16e-05	0.000447	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—GCK—gestational diabetes	8.11e-05	0.000444	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GLS2—gestational diabetes	7.33e-05	0.000402	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—CYP19A1—gestational diabetes	6.85e-05	0.000375	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—FGF2—gestational diabetes	6.82e-05	0.000374	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—FGF2—gestational diabetes	6.8e-05	0.000373	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—NAMPT—gestational diabetes	6.52e-05	0.000357	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—GCK—gestational diabetes	6.48e-05	0.000355	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—CYP19A1—gestational diabetes	6.29e-05	0.000345	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—NAMPT—gestational diabetes	6.14e-05	0.000337	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GCK—gestational diabetes	6.1e-05	0.000334	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—NAMPT—gestational diabetes	6.09e-05	0.000334	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GCK—gestational diabetes	6.05e-05	0.000332	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—CYP19A1—gestational diabetes	5.93e-05	0.000325	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—LEP—gestational diabetes	5.85e-05	0.00032	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—LEP—gestational diabetes	5.33e-05	0.000292	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—LEP—gestational diabetes	5.28e-05	0.000289	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—LEP—gestational diabetes	5.21e-05	0.000286	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—NAMPT—gestational diabetes	5.2e-05	0.000285	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GCK—gestational diabetes	5.17e-05	0.000283	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—LEP—gestational diabetes	4.93e-05	0.00027	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—LEP—gestational diabetes	4.85e-05	0.000266	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CYP19A1—gestational diabetes	4.73e-05	0.000259	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CYP19A1—gestational diabetes	4.46e-05	0.000244	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—FGF2—gestational diabetes	4.44e-05	0.000243	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CYP19A1—gestational diabetes	4.42e-05	0.000242	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—LEP—gestational diabetes	4.31e-05	0.000236	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—FGF2—gestational diabetes	4.05e-05	0.000222	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—NAMPT—gestational diabetes	4.01e-05	0.00022	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—FGF2—gestational diabetes	4.01e-05	0.00022	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—LEP—gestational diabetes	4.01e-05	0.000219	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GCK—gestational diabetes	3.99e-05	0.000219	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—FGF2—gestational diabetes	3.96e-05	0.000217	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CYP19A1—gestational diabetes	3.78e-05	0.000207	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—FGF2—gestational diabetes	3.75e-05	0.000205	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—FGF2—gestational diabetes	3.69e-05	0.000202	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—FGF2—gestational diabetes	3.27e-05	0.000179	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—FGF2—gestational diabetes	3.04e-05	0.000167	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CYP19A1—gestational diabetes	2.92e-05	0.00016	CbGpPWpGaD
